These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3895734)

  • 41. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
    Tannenbaum H; Wild J
    Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical value of the tube leukocyte adherence inhibition assay in diagnosis and prognosis of breast cancer.
    Lopez MJ; O'Connor R; MacFarlane JK; Thomson DM
    Surg Forum; 1977; 28():125-7. PubMed ID: 364712
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of the micromodified leukocyte adherence inhibition test in the diagnosis of breast cancer].
    Kharkevich DD; Sablikova IuA; Polevaia EB; Savinov AIu
    Lab Delo; 1985; (6):374-6. PubMed ID: 2413267
    [No Abstract]   [Full Text] [Related]  

  • 45. Tube LAI assay in diagnosis and monitoring of a cancer disease.
    Hasek M; Holán V; Kousalová M
    Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell populations in leucocyte adherence inhibition: requirement for T lymphocytes with IgG Fc receptors.
    Powell AE; Birch RE; Murrell H; Sloss AM
    Immunology; 1982 Aug; 46(4):689-96. PubMed ID: 7049907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Value of MS associated factors for test procedures in multiple sclerosis: 2. Angers' MS-induced substance in the LAI test].
    Lehmitz R; Meyer U; Meyer-Rienecker HJ
    Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):714-9. PubMed ID: 6366844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Leukocyte adherence inhibition test in tumor patients].
    Martínez Martínez B; Ordóñez Gallego A; Juárez Alonso S; González Barón M; Montero García JM
    Rev Esp Oncol; 1982; 29(4):735-42. PubMed ID: 6927371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
    Kalafut F; Hung PM; Novotná L; Klobusická M
    Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Demonstration of cellular immunity by means of the leukocyte adherence inhibition (LAI) test in female breast neoplasms].
    Fritze D; Ellinger K; Mayer D; Kaufmann M; Drings P; Döhnert G
    Verh Dtsch Ges Inn Med; 1978; (84):577-9. PubMed ID: 742076
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunologic monitoring in carcinoma of the breast.
    Weese JL; Oldham RK; Tormey DC; Barlock AL; Morales A; Cohen MH; West WH; Herberman RB; Alford TC; Shorb PE; Tsangaris NT; Cannon GB; Dean JH; Djeu J; McCoy JL
    Surg Gynecol Obstet; 1977 Aug; 145(2):209-18. PubMed ID: 141745
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D; Kaufmann M; Drings P; Fedra G
    Oncology; 1978; 35(6):242-5. PubMed ID: 370704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presence of "rheumatoid neoantigen-like material" in urine of patients with RA, demonstrated by use of leukocyte adherence inhibition assay.
    Tannenbaum H
    J Rheumatol Suppl; 1983 Dec; 11():97-102. PubMed ID: 6366224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial characterization of the soluble mediator of leukocyte adherence inhibition.
    Appelboom T; Pierart M; Ameryckx G; Mairesse N
    J Rheumatol; 1987 Jun; 14(3):420-5. PubMed ID: 3498031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
    Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomaterials and immune system: cellular reactivity towards PTFE and Dacron vascular substitutes pointed out by the leukocyte adherence inhibition (LAI) test.
    Lodi M; Cavallini G; Susa A; Lanfredi M
    Int Angiol; 1988; 7(4):344-8. PubMed ID: 2977398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.